2024 ACMG Annual Clinical Genetics Meeting Digital Edition
(6)
Expand Your Learning with 62 Hours of Content from the 2024 ACMG Annual Clinical Genetics Meeting Digital Edition
Image For Activity Cover
Availability
On-Demand
2 Courses
Expires on Mar 31, 2026
Cost
ACMG Member: $599.00
Non-Member: $749.00
Postdoc/Trainee (M): $199.00
Postdoc/Trainee (NM): $249.00
Student (M): $199.00
Student (NM): $249.00
Credit Offered
62 CME (AMA) Credits
62 CME (Other) Credits
62 P.A.C.E. Credits
62 NSGC Credits

First time users: You will need to check your degree as you created an ACMG account. The system designates educational credits according to your degree. Be sure you are logged in (do you see your name on the top right under the ACMG Genetics Academy logo?). If not, log in before proceeding.

For technical support, please send an email to: education@acmg.net  or call 301-718-9603.

Or click on the "Help"  icon on the left-hand side of your screen for more information.

Support Center Hours: Monday- Friday 9:00 am - 5:00 pm Eastern Time 

 

ACMG Annual Clinical Genetics Meeting Digital Edition

Date of Release: April 16, 2024

Expiration Date: March 31, 2026

Credits offered: CME, P.A.C.E.®, NSGC

Estimate time of completion: 62 hours

NSGC credit reports are sent annually (see reporting timeline below).

 

Course Description

The 2024 ACMG Annual Clinical Genetics Meeting Digital Edition will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

 

Learning Objectives

At the conclusion of this course, participants should be able to:

 

  1. Describe the advances in genetic testing including prenatal and postnatal indications, gene panels, genome sequencing, interpretation, genetic counseling, and ethical and legal issues.
  2. Review select rare and common genetic disorders, from developmental disabilities to cancer predisposition syndromes, as well as novel therapeutic approaches including gene therapy.
  3. Review select inborn errors of metabolism, approaches to their diagnoses and treatment, new disorders on the recommended newborn screening panel.
  4. Recognize the importance of diversity, equity, and Inclusion in clinical genetic care and research, and that inclusion is an essential component for the genetic workforce development.
  5. Analyze the need for innovation and new approaches to transforming the current practice of genetic medicine to achieve a vision of genomically-informed precision population health.

 

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

  • Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems.
  • Laboratory directors and technicians who conduct genetic testing.
  • Researchers involved in the discovery of genetic disorders and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences.
  • Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics.
  • Advocates for patients with genetic conditions and their families.
pdf document link

Access Begins on April 16, 2024.

*Developing Countries Rate: Those qualifying for this rate must live in a country on the World Bank Developing Country List. To request this rate, email education@acmg.net with your name and country of residence to receive a discount code.

 ** Emeritus and Honorary Rate: To qualify for this rate, you must be an ACMG Emeritus member. To request this rate, email education@acmg.net to receive a discount code.

CME AMA PRA Category 1TM, ASCLS P.A.C.E., NSGC

 

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation

The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 62 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

 

ASCLS P.A.C.E.® CEU's 

ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.

 

ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). This course is registered with CEBroker #20-1170746. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.® (275-400-24). This activity has been approved for 62 P.A.C.E.® contact hours.

 

National Society of Genetic Counselors (NSGC):

The National Society of Genetic Counselors (NSGC) has authorized American College of Medical Genetics and Genomics to offer up to 6.20 CEUs or 62 Category 1 contact hours for the activity 2024 ACMG Annual Clinical Genetics Meeting Digital Edition. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.

 

ACMG reports completed accredited sessions to NSGC for credit certificates annually.

Reporting year

Participant deadline to claim credits

ACMG reporting date

2024

12/2/2024

12/4/2024

2025

12/1/2025

12/3/2025

2026

3/30/2026

5/29/2026

 

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

 

Participation Instructions (OnDemand)

  1. Complete session by watching recordings.
  2. Pass a post-test with a score of 80% or better (Learning mode activated and reset available).
  3. Complete session evaluations

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.

*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships listed have been mitigated.

Name

Role: Presenter/Panelist/Moderator/ Liaison/Program Committee Member/Peer Reviewer

Financial Disclosure for 24 Months
(relationship is ongoing unless stated)

Abu-El-Haija, Aya

Moderator/CE Presenter

No Relevant Financial Relationships

Adams, April

Moderator/CE Presenter

No Relevant Financial Relationships

Ali, Muhammad

CE Presenter

No Relevant Financial Relationships

Amlie-Wolf, Louise

Platform Presenter

No Relevant Financial Relationships

Ayers, Kara

CE Presenter

No Relevant Financial Relationships

Bachir, Suha

CE Presenter

No Relevant Financial Relationships

Barnett,  Claudia

Program Committee Member/Staff

No Relevant Financial Relationships

Barrios, Roia

CE Presenter

No Relevant Financial Relationships

Bennett, Robin

Moderator

No Relevant Financial Relationships

Bent, Robyn

CE Presenter

No Relevant Financial Relationships

Best, Hunter

CE Presenter

No Relevant Financial Relationships

Bianchi, Diana

CE Presenter

No Relevant Financial Relationships

Bird, Lynne

Moderator

No Relevant Financial Relationships

Birsoy, Ozge

Platform Presenter

No Relevant Financial Relationships

Bivona, Stephanie

Platform Presenter

No Relevant Financial Relationships

Bowling, Kevin

CE Presenter

No Relevant Financial Relationships

Boyce, Alison

CE Presenter

Research funding: Amgen; Ultragenyx; Kyowa Kirin

Brand, Harrison

Platform Presenter

No Relevant Financial Relationships

Brothers, Kyle

CE Presenter

Research funding: Invitae

Burns, Kaitlyn

CE Presenter

Consultant: Illumina; Has ended

Callahan, Katherine

CE Presenter

No Relevant Financial Relationships

Cao, Yang

CE Presenter

No Relevant Financial Relationships

Carey, John

Moderator

Chair Safety Committee: Merck; Has ended

Cassini, Thomas

Moderator

No Relevant Financial Relationships

Chakraborty, Pranesh

CE Presenter

Research funding: Biomarin; Novartis; Takeda;  Cambrooke; Vitaflo; Nutricia
Research funding:  Biogen; Has ended
Advisory Board: Novartis; Sanofi; Ultragenyx; Waters; Horizon; Has ended

Chandra, Bharatendu

CE Presenter

No Relevant Financial Relationships

Chapman, Kimberly

CE Presenter

Consultant: Hemoshear Therapeutics

Chen, Wei-Liang

CE Presenter

No Relevant Financial Relationships

Chitayat, David

CE Presenter

No Relevant Financial Relationships

Cho, Mildred

CE Presenter

No Relevant Financial Relationships

Chung, Brian Hon-Yin

Platform Presenter

No Relevant Financial Relationships

Chung, Wendy

Platform Presenter

Board of Directors: Prime Medicine; Rallybio

Cohen, Jenna

Program Committee Member/ Staff

No Relevant Financial Relationships

Conboy, Erin

Program Committee Member/ Liaison

Consultant: Lamar Health

Cone, Kelsey

CE Presenter

No Relevant Financial Relationships

Conway, Laura

CE Presenter

No Relevant Financial Relationships

Corona, Rosario

CE Presenter

No Relevant Financial Relationships

Coughlin, Curtis

CE Presenter

No Relevant Financial Relationships

Culver, Julie

CE Presenter

No Relevant Financial Relationships

Dahlroth, Jane

Program Committee Member/ Staff

No Relevant Financial Relationships

Danos, Arpad

CE Presenter

No Relevant Financial Relationships

Dawood, Moez

Platform Presenter

No Relevant Financial Relationships

Dauber, Andrew

Platform Presenter

Consultant: Novo Nordisk; Pfizer; Bridge Bio/QED
Research funding: Pfizer
Consultant: with Tyra; Has ended

Deignan, Josh

CE Presenter

No Relevant Financial Relationships

Del Gobbo, Giulia

Platform Presenter

No Relevant Financial Relationships

Dempsey, Melissa

Moderator

Employee: Illumina

Dickson, Alexa

CE Presenter

No Relevant Financial Relationships

Diekema, Douglas

CE Presenter

No Relevant Financial Relationships

Dinulos, Mary Beth

CE Presenter

No Relevant Financial Relationships

Dipple, Katrina

Co-Moderator

No Relevant Financial Relationships

Drivas, Theodore

Platform Presenter

Consultant: Ono Pharmaceutical; Has ended

Dubuc, Adrian

CE Presenter

Consultant relationship Abbvie; Has ended

Duque Lasio, Maria Laura

CE Presenter

No Relevant Financial Relationships

Duyzend, Michael

CE Presenter

No Relevant Financial Relationships

Eddleman, Keith

Program Committee Member/ Liaison/ Moderator

Speaker’s Bureau: Mead Johnson Nutrition

Ehrenfeld, Jesse

CE Presenter

No Relevant Financial Relationships

Eldomery, Mohammad

Platform Presenter

No Relevant Financial Relationships

Ellinwood, N. Matthew

Moderator

Representative of patient advocacy: Denali Therapeutics; Regenxbio, Inc.; Takeda; BioMarin

Elliott, Alison

CE Presenter

No Relevant Financial Relationships

Elsea, Sarah

Moderator

Research funding: PTC Therapeutics; Speragen, Inc

Ewing, Altovise

CE Presenter

Employee: Roche Genentech

Farrow, Emily

Platform Presenter

Speaker's Bureau: Kyowa Kirin; Has ended

Fernandez, Jessica

CE Presenter

No Relevant Financial Relationships

Fieg, Elizabeth

CE Presenter

No Relevant Financial Relationships

Fisher, Deborah

CE Presenter

No Relevant Financial Relationships

Fortini, Barbara

CE Presenter

No Relevant Financial Relationships

Freire,  Penelope

Program Committee Member/ Staff

No Relevant Financial Relationships

Gambello, Michael

Program Committee Member/ Liaison

No Relevant Financial Relationships

Ghazani, Arezou

CE Presenter

No Relevant Financial Relationships

Gibson, Jane

CE Presenter

No Relevant Financial Relationships

Giordano, Jessica

CE Presenter

No Relevant Financial Relationships

Glass, Ian

CE Presenter

No Relevant Financial Relationships

Gold, Nina

Moderator/CE Presenter

Consultant: RCG Consulting, LLC
Speaker’s Bureau: Ambyr Genetics

Gold, Jessica

CE Presenter

No Relevant Financial Relationships

Goldstein, Jennifer

Platform Presenter

No Relevant Financial Relationships

Gracia, Clarisa

CE Presenter

No Relevant Financial Relationships

Gorzynski, John

CE Presenter

No Relevant Financial Relationships

Gray, Shannon

Co-Moderator

No Relevant Financial Relationships

Gray, Kathryn

CE Presenter

Scientific Medical Advisor: BillionToOne
Consultant: Aetion; Roche; Has ended

Griffith, Obi

Moderator/CE Presenter

No Relevant Financial Relationships

Groopman, Emily

Platform Presenter

No Relevant Financial Relationships

Gropman, Andrea

Moderator/CE Presenter

No Relevant Financial Relationships

Gu, Shen

Platform Presenter

No Relevant Financial Relationships

Guha, Saurav

CE Presenter

No Relevant Financial Relationships

Guzman, Herodes

Co-Moderator

No Relevant Financial Relationships

Haldeman-Englert, Chad

Moderator/CE Presenter

Consultant: Illumina

Hamadeh, Zeid

Platform Presenter

No Relevant Financial Relationships

Hamilton, Afifa

CE Presenter

Employee: eviCore Healthcare

Hand, Jennifer

CE Presenter

Section Editor: UpToDate, Inc

Harmatz, Paul

CE Presenter

Consultant: Aeglea; Audentes; Capsida; Chiesi; Edigene; Renoviron; Saliogen; Inventiva Pharma; Has ended
Consultant: Grace Science; Rallybio; Neurogene; Novel Pharma; Orchard Therapeutics
Research funding: Adrenas; Amicus; Ascendis; ASPA; Azafaros; BioMarin; Calcilytics; Denali; Homology; JCR Pharmaceuticals; Orphazyme; QED Therapeutics; RegenXbio; Sangamo; Takeda; Idorsia; Prevail; Allievex

Harr, Margaret

CE Presenter

No Relevant Financial Relationships

Hisama, Fuki

Moderator/CE Presenter

No Relevant Financial Relationships

Hoffman, Jodi

Program Committee Member/ Liaison/ Moderator

No Relevant Financial Relationships

Holm, Ingrid

CE Presenter

Consultant: Biomarin

Hoover-Fong, Julie

CE Presenter

Consultant: Biomarin; QED Therapeutics
Scientific Medical Advisor: Biomarin; QED Therapeutics
Research funding: QED; Biomarin; Innoskel

Hopkin, Robert

CE Presenter

Consultant: Aro Biotherapeutics; Has ended
Honoraria: Amicus Therapeutics
Scientific Medical Advisor: Chiesi Farmaceutici; Denali Therapeutics; Sangamo Therapeutics; Sanofi; Acadia Pharmaceuticals

Hoppman, Nicole

Moderator/CE Presenter

No Relevant Financial Relationships

Huang, Yue

CE Presenter

Scientific Medical Advisor: Horizon Therapeutics

Hufnagel, Robert

CE Presenter

No Relevant Financial Relationships

Hurst, Anna

Moderator

Consultant: CFD Research

Jarvik, Gail

CE Presenter

No Relevant Financial Relationships

Jeng, Linda

CE Presenter

No Relevant Financial Relationships

Ji, Yuan

Moderator/CE Presenter

No Relevant Financial Relationships

Jobanputra, Vaidehi

Platform Presenter

Consultant: Illumina; Has ended

Justice, Anne

CE Presenter

No Relevant Financial Relationships

Kalantari, Forouh

Platform Presenter

No Relevant Financial Relationships

Kellis, Manolis

CE Presenter

No Relevant Financial Relationships

Kelly, Melissa

Platform Presenter

No Relevant Financial Relationships

Kim,  Jaeseung

Program Committee Member/ Liaison

No Relevant Financial Relationships

King, Jennifer

Program Committee Member/ Liaison/ Moderator

Consultant: Sonio

Kingsmore, Stephen

CE Presenter

No Relevant Financial Relationships

Klugman, Susan

Program Committee/ Board of Directors Liaison/ Moderator/ CE Presenter

No Relevant Financial Relationships

Knoppers, Bartha Maria

CE Presenter

No Relevant Financial Relationships

Kobren, Shilpa

Moderator

No Relevant Financial Relationships

Kopp,  Nathan

Program Committee Member/ Liaison

No Relevant Financial Relationships

Korson, Mark

CE Presenter

Research funding: Recordati
Consultant: HemoShear
Research: Aeglea; Travere; Has ended
Consultant: Glycomine; Eton; Acer; Tessera; Solace Nutrition; Has ended
Speaker's Bureau: Moderna; Has ended

Kozel, Beth

CE Presenter

No Relevant Financial Relationships

Kritzer, Amy

CE Presenter

No Relevant Financial Relationships

Krstic, Nevena

CE Presenter

No Relevant Financial Relationships

Kulchak Rahm,  Alanna

Program Committee Member/ Liaison

No Relevant Financial Relationships

Landrum, Melissa

CE Presenter

No Relevant Financial Relationships

Larson, Austin

CE Presenter

Consultant: Illumina; Entrada Therapeutics; Has ended
Consultant: Travere; Stealth Biotherapeutics; Astellas; UCB Pharma; Tisento

Lee, Brendan

CE Presenter

Royalties: Sanofi; Pacira; GQ BIO Therapeutics; Acer Therapeutics
Consultant: Biomarin

Legare, Janet

CE Presenter

Speaker's Bureau: BioMarin; QED/Bridge Bio

Lemke, Amy

Program Committee Member/ Liaison/ Co-Moderator

No Relevant Financial Relationships

Leung, Marco

CE Presenter

No Relevant Financial Relationships

Lewis, Robert

Platform Presenter

No Relevant Financial Relationships

Li, Hong

Moderator/CE Presenter

Consultant: Logicbio;Travere
Consultant: Homology; Moderna; Has ended;
Scientific Medical Advisor: Ultragenyx; Has ended;
Consultant: Acer Therapeutics; Has ended;
Research funding: Hemoshear

Li, Marilyn

CE Presenter

Consultant: Agilent Technologies; Bayer Pharmaceuticals; Has ended

Li, Dong

Platform Presenter

No Relevant Financial Relationships

Lianoglou, Billie

CE Presenter

No Relevant Financial Relationships

Ligon, Azra

CE Presenter

No Relevant Financial Relationships

Lin, Angela

CE Presenter

No Relevant Financial Relationships

Liu, Shuxi

CE Presenter

Employee: GeneDx

Liu, Pengfei

CE Presenter

No Relevant Financial Relationships

Lockwood, Christina

CE Presenter

Scientific Medical Advisor: LGC Group

Luperchio, Teresa

Co-Moderator

Stock: Invitae; Natera; Ionis Pharmaceuticals; Moderna; Nokia

Madjunkov, Mitko

Platform Presenter

No Relevant Financial Relationships

Malkin, David

CE Presenter

No Relevant Financial Relationships

Manickavasagam Amudhavalli,  Shivarajan

Program Committee Member/ Liaison

No Relevant Financial Relationships

Manolio,  Teri

Program Committee Member/ Liaison

No Relevant Financial Relationships

Maxwell, Kara

CE Presenter

No Relevant Financial Relationships

McClure, Michelle

Co-Moderator

Stock: Abeona; Bionano

McDonald-McGinn, Donna

Moderator

Scientific Medical Advisor: Natera

McGowan, Michelle

CE Presenter

No Relevant Financial Relationships

McNeil, Shannon

CE Presenter

No Relevant Financial Relationships

Meredith, Stephanie

Co-Moderator

No Relevant Financial Relationships

Micke, Kestutis

CE Presenter

No Relevant Financial Relationships

Miller, Danny

CE Presenter

Stock: MyOme; Has ended
Research funding: Oxford Nanopore Technologies

Mintz, Kevin

CE Presenter

No Relevant Financial Relationships

Morales Corado, Andres

Program Committee Member/ Therapeutics Liaison / Moderator/CE Presenter

Research funding: Phoenix Nest Inc.

Morava, Eva

CE Presenter

No Relevant Financial Relationships

Mori, Mari

Moderator

No Relevant Financial Relationships

Morton, Cynthia

CE Presenter

No Relevant Financial Relationships

Mosera, Mackenzie

Moderator

No Relevant Financial Relationships

Mosley, Jonathan

CE Presenter

No Relevant Financial Relationships

Mueller, Daniel

CE Presenter

No Relevant Financial Relationships

Muthusamy, Karthik

CE Presenter

No Relevant Financial Relationships

Myers, Melanie

CE Presenter

No Relevant Financial Relationships

Novotny, Edward 'Rusty'

CE Presenter

Advisory Board: UCB Pharmaceuticals
Scientific Medical Advisor: Jazz Pharmaceuticals

Null, Elizabeth

Moderator

No Relevant Financial Relationships

Offord, Stephanie

CE Presenter

Consultant: Illumina; Has ended

Omorodion, Jacklyn

Platform Presenter

No Relevant Financial Relationships

Paras, Andrea

Platform Presenter

No Relevant Financial Relationships

Parikh, Aditi

Program Committee Member/ Education Liaison/ Moderator

No Relevant Financial Relationships

Patterson, Wesley

CE Presenter

Consultant: Illumina, Inc.; Has ended

Peay, Holly

CE Presenter

Research funding: Sarepta Therapeutics; Travere Therapeutics; Janssen Pharmaceuticals; Orchard Therapeutics

Peck, Larissa

Platform Presenter

Speaker's Bureau: AstraZeneca; Merck; Invitae; Has ended
Consultant: AstraZeneca; Has ended

Pena, Loren

Moderator

Consultant: CVS Caremark; Cyclo Therapeutics Inc; Moderna
Research funding:  Zevra Pharma

Pereira, Elaine

CE Presenter

No Relevant Financial Relationships

Petry, Natasha

CE Presenter

Stock: Teva Pharmaceutical; Has ended

Phillips, John

CE Presenter

No Relevant Financial Relationships

Pope, Kathleen

Moderator

No Relevant Financial Relationships

Posey, Jennifer

CE Presenter

No Relevant Financial Relationships

Powell, Cynthia

CE Presenter

No Relevant Financial Relationships

Powell, Sabrina

Platform Presenter

No Relevant Financial Relationships

Prakash Bharwani, Karishma

Co-Moderator

No Relevant Financial Relationships

Pritchard, Amanda

CE Presenter

Research funding: Applied Therapeutics; Moderna

Prows, Cynthia

Moderator

No Relevant Financial Relationships

Pruthi, Sandhya

CE Presenter

No Relevant Financial Relationships

Punnoose, Ann

CE Presenter

No Relevant Financial Relationships

Raca, Gordana

CE Presenter

No Relevant Financial Relationships

Radford, Jane

Program Committee Member/ Staff

No Relevant Financial Relationships

Rana, Huma

CE Presenter

No Relevant Financial Relationships

Reddi, Honey

CE Presenter

Consultant: Biofidelity Inc

Regier, Debra

CE Presenter

No Relevant Financial Relationships

Rehder, Catherine

CE Presenter

Consultant: Amicus Theraputics; Alexion Pharmaceuticals; Has ended
Research funding: Amicus Therapeutics; Alexion Pharmaceuticals

Rehm, Heidi

CE Presenter

Research funding: Microsoft

Restrepo, Michael

Platform Presenter

No Relevant Financial Relationships

Rosenfeld, Jill

CE Presenter

No Relevant Financial Relationships

Rowsey, Ross

Program Committee Member/ Liaison/ Modrerator/CE presenter

No Relevant Financial Relationships

Ruzhnikov, Maura

Moderator

No Relevant Financial Relationships

Sadle, Charles

CE Presenter

No Relevant Financial Relationships

Saunders, Carol

Platform Presenter

No Relevant Financial Relationships

Savage, Sharon

CE Presenter

No Relevant Financial Relationships

Schaaf, Christian

CE Presenter

No Relevant Financial Relationships

Schelhaas, Andrea

Moderator